Featured Research

from universities, journals, and other organizations

Lawrence Livermore Lab Pioneers Advanced Radiation Treatment For Cancer

Date:
October 11, 2000
Source:
Lawrence Livermore National Laboratory
Summary:
Mankind will soon have another weapon in the 4,000-year fight against cancer. Clearance has been granted by the U.S. Food & Drug Administration for an advanced method for targeting tumors with radiation treatment developed by researchers at the U.S. Department of Energy’s Lawrence Livermore National Laboratory.

Nomos Corp. receives Food & Drug Administration clearance for new technology

LIVERMORE, Calif. — Mankind will soon have another weapon in the 4,000-year fight against cancer. Clearance has been granted by the U.S. Food & Drug Administration for an advanced method for targeting tumors with radiation treatment developed by researchers at the U.S. Department of Energy’s Lawrence Livermore National Laboratory.

Dubbed Peregrine — after the patron saint of cancer patients — the technology could eventually save thousands of lives each year by helping doctors direct more radiation at tumors, with minimal damage to surrounding healthy tissue.

NOMOS Corporation, a leading supplier of radiation treatment technologies located in Sewickley, PA recently received U.S. Food & Drug Administration clearance to produce and market Peregrine systems to the medical community.

Secretary of Energy Bill Richardson made the announcement today at NOMOS headquarters. "Peregrine could change the way cancer is treated in America," said Secretary Richardson. "This technology was developed through advances resulting from nuclear weapons research and with the multidisciplinary scientific expertise of a Department of Energy national laboratory. This is an excellent example of turning swords into plowshares."

Peregrine has been under development at Lawrence Livermore since 1994, in collaboration with researchers at the University of California, San Francisco and other academic institutions.

More Radiation Where It’s Needed

Peregrine is a computer-based system for calculating, in three dimensions, where radiation goes in the body, and how much of it is striking tissue, bone or empty cavities. Peregrine will allow doctors to more accurately target tumors with radiation, permitting physicians to increase the dose needed to destroy tumors without increasing damage to healthy surrounding tissue. Each year, more than 100,000 cancer patients who are treated with radiation in hopes of a cure die with active tumors at the primary cancer site. Improved dose calculations using Peregrine could help doctors more effectively attack such tumors.

"Peregrine will touch lives," said Christine Hartmann Siantar, the Livermore Lab’s principal Peregrine researcher. "It is a breakthrough technology that can be used in treatment clinics everywhere." John A. Friede, Chairman, President and Chief Executive Officer of NOMOS Corporation, said, "The combined efforts of the NOMOS and LLNL Peregrine teams to compile the data necessary to obtain FDA clearance has been extraordinary."

"We can now offer this unparalleled technology to doctors and clinicians who can provide ‘better medicine’ for cancer patients, underscoring our commitment to improving the treatment of cancer as well as the lives of cancer patients throughout the world."

Monte Carlo Improves The Odds

Peregrine combines Livermore’s almost 50 years of radiation physics expertise with advanced computer architectures to produce a system that determines radiation dose information in minutes.

Peregrine relies on a mathematical technique called Monte Carlo to track radiation. It simulates the trillions of radiation particles that enter the body during treatment and accurately predicts radiation dose. Peregrine uses individual patient CT scans to tailor precise radiation dose calculations for each patient, based on each patient’s distinct anatomy and disease. Researchers at the University of California, San Francisco worked closely with Livermore scientists during development and validation of Peregrine. "Our collaboration convinced us that this program will be able to accurately predict dose distributions for the most complex intensity modulated radiotherapy plans," said Lynn Verhey, Ph.D., professor and Vice-Chair, Department of Radiation Oncology, UCSF. "The Peregrine program will allow us to use the system clinically to plan and deliver these radiotherapy plans with greater confidence."

Multi-Disciplinary Capability Produced Peregrine

Making Peregrine a reality required the expertise of Livermore researchers from a number of disciplines, including physicists, computer scientists and electrical engineers.

"We’re extremely pleased to be able to advance science in an area of great human significance," said Jeff Wadsworth, Livermore’s deputy director for Science and Technology. "That’s what Lawrence Livermore is all about."

NOMOS’ initial deployment of Peregrine will be incorporated into its own inverse treatment planning system, called CORVUS, and will be showcased at the upcoming meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) scheduled to be held in Boston, October 22-26. A stand-alone version of Peregrine will subsequently be developed to work with other treatment planning systems, making its unmatched capability and accuracy available to every cancer patient.

City of Hope Cancer Center in Los Angeles will be one of the first organizations to use Peregrine. "We are excited that we will be able to offer our patients the latest in radiation therapy technology," said Jeffrey Wong, M.D., Chair, Division of Radiation Oncology, City of Hope. NOMOS Corporation is the world’s leading supplier of planning and delivery technology for intensity modulated radiation therapy (IMRT). NOMOS introduced IMRT, which has been described as the most significant breakthrough in cancer therapy in the past 30 years, to the oncology industry in 1992. The company is also a leading supplier of 3-D planning systems. To find out more about NOMOS and its treatment planning and delivery products, visit the NOMOS website at www.nomos.com. Founded in 1952, Lawrence Livermore National Laboratory is a national security laboratory, with a mission to ensure national security and apply science and technology to the important issues of our time. Lawrence Livermore National Laboratory is managed by the University of California for the U.S. Department of Energy. More information on Peregrine can be found at http://www.llnl.gov/peregrine


Story Source:

The above story is based on materials provided by Lawrence Livermore National Laboratory. Note: Materials may be edited for content and length.


Cite This Page:

Lawrence Livermore National Laboratory. "Lawrence Livermore Lab Pioneers Advanced Radiation Treatment For Cancer." ScienceDaily. ScienceDaily, 11 October 2000. <www.sciencedaily.com/releases/2000/10/001009105033.htm>.
Lawrence Livermore National Laboratory. (2000, October 11). Lawrence Livermore Lab Pioneers Advanced Radiation Treatment For Cancer. ScienceDaily. Retrieved August 22, 2014 from www.sciencedaily.com/releases/2000/10/001009105033.htm
Lawrence Livermore National Laboratory. "Lawrence Livermore Lab Pioneers Advanced Radiation Treatment For Cancer." ScienceDaily. www.sciencedaily.com/releases/2000/10/001009105033.htm (accessed August 22, 2014).

Share This




More Matter & Energy News

Friday, August 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Is It a Plane? No, It's a Hoverbike

Is It a Plane? No, It's a Hoverbike

Reuters - Business Video Online (Aug. 22, 2014) UK-based Malloy Aeronautics is preparing to test a manned quadcopter capable of out-manouvering a helicopter and presenting a new paradigm for aerial vehicles. A 1/3-sized scale model is already gaining popularity with drone enthusiasts around the world, with the full-sized manned model expected to take flight in the near future. Matthew Stock reports. Video provided by Reuters
Powered by NewsLook.com
Coal Gas Boom in China Holds Climate Risks

Coal Gas Boom in China Holds Climate Risks

AP (Aug. 22, 2014) China's energy revolution could do more harm than good for the environment, despite the country's commitment to reducing pollution and curbing its carbon emissions. (Aug. 22) Video provided by AP
Powered by NewsLook.com
Former TSA X-Ray Scanners Easily Tricked To Miss Weapons

Former TSA X-Ray Scanners Easily Tricked To Miss Weapons

Newsy (Aug. 21, 2014) Researchers found the scanners could be duped simply by placing a weapon off to the side of the body or encasing it under a plastic shield. Video provided by Newsy
Powered by NewsLook.com
Flower Power! Dandelions Make Car Tires?

Flower Power! Dandelions Make Car Tires?

Reuters - Business Video Online (Aug. 20, 2014) Forget rolling on rubber, could car drivers soon be traveling on tires made from dandelions? Teams of scientists are racing to breed a type of the yellow flower whose taproot has a milky fluid with tire-grade rubber particles in it. As Joanna Partridge reports, global tire makers are investing millions in research into a new tire source. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins